NNT735 - VESICULAR NANO DRUG DELIVERY SYSTEMS and THEIR USE
| Course Name | Code | Semester | Theory (hours/week) |
Application (hours/week) |
Credit | ECTS |
|---|---|---|---|---|---|---|
| VESICULAR NANO DRUG DELIVERY SYSTEMS and THEIR USE | NNT735 | Any Semester/Year | 3 | 0 | 3 | 9 |
| Prequisites | None | |||||
| Course language | Turkish | |||||
| Course type | Elective | |||||
| Mode of Delivery | Face-to-Face | |||||
| Learning and teaching strategies | Lecture Preparing and/or Presenting Reports | |||||
| Instructor (s) | Prof. Dr. Suna ErdoÄŸan | |||||
| Course objective | In this lecture, it is aimed to give information about properties, charcahterization, preparation and in vivo application of nano drug delivery systems containing different contrast agent used for different imaging modalities. | |||||
| Learning outcomes |
| |||||
| Course Content | Rontgen, computed tomography, magnetic resonance imaging, ultrasonography and radionuclidic imaging modalities, contrast agents used for these imaging modalities and contrast agent loaded nano drug delivery sytems | |||||
| References | 1- G. Gregoriadis (Ed), Liposome Technology, New York : Informa Healthcare 2007. 2- S.C. Basu, M. Basu (Eds), Liposome Methods and Protocols Totowa, N.J. : Humana Press, 2002. 3- D.D. Lasic (Ed), Liposmes from Physic to Application, Elsevier, Amsterdam, 1993. 4- A. Gursoy (Ed), Kontrollu Salim Sistemleri, Kontrollü Salım Sistemleri Derneği. İstanbul, 2004. 5- V. Weissig (ed), Liposomes: Methods and Protocols, Vloume 1: Pharmaceutcial Nanocarriers, New York, Humana Press, 2010. | |||||
Course outline weekly
| Weeks | Topics |
|---|---|
| Week 1 | Introduction |
| Week 2 | Terminology, radioactivity, radiation material interference |
| Week 3 | X-Ray Imaging |
| Week 4 | Computed Tomography Imaging Modality |
| Week 5 | Magnetic Resonance Imaging Modality |
| Week 6 | Midterm exam |
| Week 7 | Ultrasonography |
| Week 8 | Radionuclidic Imaging Modalities |
| Week 9 | Contrast Agents Used in Diagnostic Imaging Modalities |
| Week 10 | Nano Drug Delivery Systems Loaded with Contrast Agent |
| Week 11 | Midterm exam |
| Week 12 | Nano Drug Delivery Systems Loaded with Contrast Agent |
| Week 13 | Nano Drug Delivery Systems Loaded with Contrast Agent |
| Week 14 | Nano Drug Delivery Systems Loaded with Contrast Agent |
| Week 15 | Nano Drug Delivery Systems Loaded with Contrast Agent |
| Week 16 | Final Exam |
Assesment methods
| Course activities | Number | Percentage |
|---|---|---|
| Attendance | 14 | 0 |
| Laboratory | 0 | 0 |
| Application | 0 | 0 |
| Field activities | 0 | 0 |
| Specific practical training | 0 | 0 |
| Assignments | 0 | 0 |
| Presentation | 1 | 25 |
| Project | 0 | 0 |
| Seminar | 0 | 0 |
| Midterms | 1 | 25 |
| Final exam | 1 | 50 |
| Total | 100 | |
| Percentage of semester activities contributing grade succes | 0 | 50 |
| Percentage of final exam contributing grade succes | 0 | 50 |
| Total | 100 | |
WORKLOAD AND ECTS CALCULATION
| Activities | Number | Duration (hour) | Total Work Load |
|---|---|---|---|
| Course Duration (x14) | 14 | 3 | 42 |
| Laboratory | 0 | 0 | 0 |
| Application | 0 | 0 | 0 |
| Specific practical training | 0 | 0 | 0 |
| Field activities | 0 | 0 | 0 |
| Study Hours Out of Class (Preliminary work, reinforcement, ect) | 14 | 4 | 56 |
| Presentation / Seminar Preparation | 2 | 25 | 50 |
| Project | 0 | 0 | 0 |
| Homework assignment | 1 | 7 | 7 |
| Midterms (Study duration) | 1 | 55 | 55 |
| Final Exam (Study duration) | 1 | 60 | 60 |
| Total Workload | 33 | 154 | 270 |
Matrix Of The Course Learning Outcomes Versus Program Outcomes
| D.9. Key Learning Outcomes | Contrubition level* | ||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | |
| 1. To be able to use mathematics, science and engineering knowledge to develop new methods in nanotechnology and nanomedicine | X | ||||
| 2. To have comprehensive information on the current techniques and methods applied in nanotechnology and nanomedicine | X | ||||
| 3. To develop methods and tools for the identification and understanding of functions and interaction mechanisms at the atomic and molecular level | X | ||||
| 4. To understand the effects of universal and social aspects in nanotechnology and nanomedicine applications. | X | ||||
| 5. To be able to use new technological developments, databases and other knowledge sources efficiently by adopting the importance of life-long learning | X | ||||
| 6. To acquire the ability of analysis, synthesis and evaluation of new ideas and developments in nanotechnology and nanomedicine | X | ||||
| 7. To have awareness of entrepreneurship and innovativeness | X | ||||
| 8. To be able to design an experiment, analyze and interpret the experimental results as a written report. | X | ||||
| 9. An ability to perform disciplinary and interdisciplinary team work | X | ||||
| 10. An ability to present the results of the studies orally or written in national and international platforms and contribute to the scientific literature. | X | ||||
| 11. To have consciousness about professional ethics and social responsibility | X | ||||
*1 Lowest, 2 Low, 3 Average, 4 High, 5 Highest